Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Rituximab for opsoclonus myoclonus ataxia syndrome associated with neuroblastoma.

× No keyword cloud information.

5 in total

Review 1. Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004.

Authors: Katherine K Matthay; Franz Blaes; Barbara Hero; Dominique Plantaz; Pedro De Alarcon; Wendy G Mitchell; Michael Pike; Vito Pistoia
Journal: Cancer Lett Date: 2005-10-18 Impact factor: 8.679

Review 2. Overview of the clinical development of rituximab: first monoclonal antibody approved for the treatment of lymphoma.

Authors: A J Grillo-López; C A White; C Varns; D Shen; A Wei; A McClure; B K Dallaire
Journal: Semin Oncol Date: 1999-10 Impact factor: 4.929

3. Immunologic and clinical responses to rituximab in a child with opsoclonus-myoclonus syndrome.

Authors: Michael R Pranzatelli; Elizabeth D Tate; Anna L Travelstead; Darryl Longee
Journal: Pediatrics Date: 2004-12-15 Impact factor: 7.124

4. Opsoclonus-ataxia caused by childhood neuroblastoma: developmental and neurologic sequelae.

Authors: Wendy G Mitchell; Yolanda Davalos-Gonzalez; Virdette L Brumm; Sonia K Aller; Elvira Burger; Susan B Turkel; Mark S Borchert; Susan Hollar; Sonia Padilla
Journal: Pediatrics Date: 2002-01 Impact factor: 7.124

5. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study.

Authors: E Rudnick; Y Khakoo; N L Antunes; R C Seeger; G M Brodeur; H Shimada; R B Gerbing; D O Stram; K K Matthay
Journal: Med Pediatr Oncol Date: 2001-06

5 in total